Drug giant GlaxoSmithKline PLC is cutting back on its U.S. television advertising as it tries to spend its money more wisely and avoid some of the criticism aimed at heavy drug advertising, Chief Executive Andrew Witty said.
Glaxo is the world's second-biggest drug maker by sales and one of the biggest advertisers in an industry that spent more than $5.2 billion on U.S. consumer ads in 2007. Television advertising has been an especially important marketing weapon for pharmaceutical companies in promoting drug brands, even as it attracts ...
http://online.wsj.com/article/SB123154429495469531.html?mod=dist_smartbrief
